全球哮喘防治创议(GINA): 25年后（Eur Respir J）
2020/02/11
摘要
全球哮喘防治创议（GINA）于1993年在美国国家心肺和血液研究院、美国国立卫生研究院和世界卫生组织的主持下发起，以制定哮喘控制和预防的全球战略。如今，作为一个非营利性实体，它继续每年制作一份被引用最广的循证报告，内容涉及旨在全球范围内使用的成年人及儿童哮喘的最佳管理。尽管GINA报告经常被视为和用作哮喘治疗的指南，但其旨在成为一个以临床为导向的战略文件，来支持不同国家和地区实践指南的发展。其他GINA产品，包括报告的袖珍指南、教学幻灯片和实施工具也免费提供给公众使用。 GINA科学委员会是由来自一级、二级和三级护理中心的知名国际专家组成，他们积极参与患者的护理和哮喘的研究。GINA大会是一个交流科学信息和讨论各个国家改善哮喘护理举措的论坛，重点是策略的实施。GINA在制定有关哮喘诊断和治疗的研究中发挥着作用，并对护理实践指南要点和决策支持工具的发展进行通知。GINA支持提出以下目标：提高对哮喘的认识，改善哮喘患者的治疗方法和护理质量，以及提出并推广不断更新的循证治疗方法，以供全球使用。
The Global Initiative for Asthma (GINA): 25 years later.
Boulet LP.et al. Eur Respir J. 2019 Aug 29.
Abstract
The Global Initiative for Asthma (GINA) was launched in 1993 under the auspices of the National Heart, Lung, and Blood Institute, National Institutes of Health, USA, and the World Health Organization to produce a global strategy on asthma management and prevention. Now constituted as a non-profit entity, it continues to produce, on an annual basis, the most widely cited evidence-based report on the optimal management of asthma in both adults and children intended for global use. Although the GINA Report is often viewed and used as an asthma treatment guideline, it is designed to be a clinically oriented strategy document that supports the development of practice guidelines in different countries and regions.Other GINA products, including the report's pocket guides, teaching slide kits and implementation tools, are also offered free of charge for public use. The GINA Scientific Committee comprises recognised international experts from primary, secondary and tertiary centres of care who are actively involved in both the care of patients and research in asthma. The GINA Assembly is a forum for exchange of scientific information and discussions on initiatives to improve asthma care in various countries, focusing on implementation strategies. GINA plays a role in shaping research on the diagnosis and treatment of asthma and informs the development of point of care practice guides and decision support tools. GINA supports the objectives of raising awareness of asthma and improving access to therapy and quality of care for asthmatic patients, in addition to presenting and promoting continuously updated evidence-based treatment approaches for global use.
全球哮喘防治创议（GINA）于1993年在美国国家心肺和血液研究院、美国国立卫生研究院和世界卫生组织的主持下发起，以制定哮喘控制和预防的全球战略。如今，作为一个非营利性实体，它继续每年制作一份被引用最广的循证报告，内容涉及旨在全球范围内使用的成年人及儿童哮喘的最佳管理。尽管GINA报告经常被视为和用作哮喘治疗的指南，但其旨在成为一个以临床为导向的战略文件，来支持不同国家和地区实践指南的发展。其他GINA产品，包括报告的袖珍指南、教学幻灯片和实施工具也免费提供给公众使用。 GINA科学委员会是由来自一级、二级和三级护理中心的知名国际专家组成，他们积极参与患者的护理和哮喘的研究。GINA大会是一个交流科学信息和讨论各个国家改善哮喘护理举措的论坛，重点是策略的实施。GINA在制定有关哮喘诊断和治疗的研究中发挥着作用，并对护理实践指南要点和决策支持工具的发展进行通知。GINA支持提出以下目标：提高对哮喘的认识，改善哮喘患者的治疗方法和护理质量，以及提出并推广不断更新的循证治疗方法，以供全球使用。
（中国医科大学附属第一医院 李文扬 摘译 杨冬 审校）
（Boulet LP.et al. Eur Respir J. 2019 Aug 29.）
（Boulet LP.et al. Eur Respir J. 2019 Aug 29.）
The Global Initiative for Asthma (GINA): 25 years later.
Boulet LP.et al. Eur Respir J. 2019 Aug 29.
Abstract
The Global Initiative for Asthma (GINA) was launched in 1993 under the auspices of the National Heart, Lung, and Blood Institute, National Institutes of Health, USA, and the World Health Organization to produce a global strategy on asthma management and prevention. Now constituted as a non-profit entity, it continues to produce, on an annual basis, the most widely cited evidence-based report on the optimal management of asthma in both adults and children intended for global use. Although the GINA Report is often viewed and used as an asthma treatment guideline, it is designed to be a clinically oriented strategy document that supports the development of practice guidelines in different countries and regions.Other GINA products, including the report's pocket guides, teaching slide kits and implementation tools, are also offered free of charge for public use. The GINA Scientific Committee comprises recognised international experts from primary, secondary and tertiary centres of care who are actively involved in both the care of patients and research in asthma. The GINA Assembly is a forum for exchange of scientific information and discussions on initiatives to improve asthma care in various countries, focusing on implementation strategies. GINA plays a role in shaping research on the diagnosis and treatment of asthma and informs the development of point of care practice guides and decision support tools. GINA supports the objectives of raising awareness of asthma and improving access to therapy and quality of care for asthmatic patients, in addition to presenting and promoting continuously updated evidence-based treatment approaches for global use.
上一篇：
现在是时候改变我们治疗轻度哮喘的方法了：GINA 2019的最新更新
下一篇：
ERS/EAACI关于成人哮喘重度急性加重的声明：事实、优先事项和关键研究问题。
